MULTI-TINE PROBE AND TREATMENT BY ACTIVATION OF OPPOSING TINES

• US 20090076500A1
• Filed: 09/15/2008
• Published: 03/19/2009
• Est. Priority Date: 09/14/2007
• Status: Abandoned Application

• Current Assignee: LaZure Scientific Inc.
• Original Assignee: Lazure Technologies, LLC
• Inventors: Azure, Larry
• Application Number:
  US12/210,956
• Publication Number:
  US 20090076500A1
• Time in Patent Office: Days
• US Class Current: 606/41
• CPC Class Codes: A61B 18/14 Probes or electrodes therefor
• CPC Class Codes: A61B 18/1477 Needle-like probes
• CPC Class Codes: A61B 2018/00267 having a basket shaped structure
• CPC Class Codes: A61B 2018/00577 Ablation
• CPC Class Codes: A61B 2018/1407 Loop
• CPC Class Codes: A61B 2018/143 multiple needles
• CPC Class Codes: A61B 2018/1475 Electrodes retractable in or deployable from a housing

Abstract

The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or mild hyperthermia, and preferential or selective ablation of cancerous cells of target tissue regions. A method can include, for example, advancing a probe comprising a plurality of electrodes to a target tissue region comprising cancerous cells, and deploying the plurality of electrodes from a distal portion of a probe, and applying an alternating current so as to provide one or more electric fields extending through the volume and selectively or preferentially destroy cancerous cells within the volume.

Claims

1. A method of delivering an electrical field to a tissue, comprising:

advancing a probe comprising a plurality of electrodes to a target tissue region comprising cancerous cells, and deploying the plurality of electrodes from a distal portion of a probe so as to at least partially define an ablation volume with the deployed electrodes;

applying an electrical current to the ablation volume so as to provide one or more electric fields extending through the volume and selectively destroying cancerous cells within the volume.

2. The method of claim 1, wherein electrodes of the plurality comprise an insulated portion and a non-insulated portion.

3. The method of claim 2, wherein a non-insulated portion of an electrode defines an electrically active portion of the electrode.

4. The method of claim 1, wherein the electrodes are activated in pairs, with electrodes of each pair having an opposing polarity.

5. The method of claim 4, wherein electrode pairs are activated in a sequence.

6. The method of claim 1, wherein the cancerous cell destruction comprises low-power, and mild hyperthermia comprising an average tissue temperature less than about 48 degrees C., so as to preferentially ablate cancerous tissue or cells in the target tissue region.

7. The method of claim 6, wherein the electrical current comprises an alternating electrical current having a frequency between about 50 kHz and about 300 kHz.

8. The method of claim 6, wherein the electrical current provides a voltage field less than about 50 V/cm.

9. The method of claim 1, wherein the target tissue region comprises a tumor and the tumor is substantially disposed within the ablation volume.

10. The method of claim 1, wherein an applied voltage field is substantially aligned with division axes of dividing cancerous cells of the target tissue predicted based on tumor physiology.

11. The method of claim 1, wherein the applied electric field disrupts cellular membrane integrity or cell cycle progression of dividing cancerous cells.

12. The method of claim 1, wherein the applied electric field provides at least partial liquification of cancerous cells of the ablation volume.

16. The method of claim 1, wherein the cancerous cells are substantially disposed within the ablation volume.

13. A method of delivering an electrical field to a tissue, comprising:

advancing a probe comprising a plurality of electrodes to a target tissue region comprising cancerous cells and positioning electrodes of the probe so as to at least partially define an ablation volume with the positioned electrodes; and

preferentially ablating cancerous cells of the volume, the ablating comprising delivering a plurality of electric fields extending through an approximate center location of the volume, the plurality of fields comprising a first electric field, a second electric field having an angle relative to the first field, and a third electric field having an angle relative to the first and second fields.

14. The method of claim 13, the first field extending between active portions of a first pair of opposing electrodes;

the second field extending between active portions of a second pair of electrodes; and

the third field extending between active portions of a third pair of electrodes.

15. The method of claim 14, wherein the active portions comprise non-insulated portions of the electrodes.

17. A device for delivering an electric field to a tissue to destroy cancerous cells therein, the device comprising:

a probe having a plurality of electrodes positionable at a target tissue region, the plurality of electrodes deployable from a distal portion of the probe so as to at least partially define an ablation volume, the plurality comprising electrode pairs configured to provide electric fields extending through the volume and preferentially destroying cancerous cells within the volume.

18. The device of claim 17, wherein each electrode of the plurality comprises an electrically active portion.

19. The device of claim 18, wherein the electrically active portion comprises a non-insulated portion of the electrode.

20. The device of claim 17, wherein each electrode pair is configured to deliver an electric field having a angle relative to fields delivered from other electrode pairs of the plurality.

21. The device of claim 17, further comprising a microcatheter tube deployable from the distal portion of the probe and an electrode of the plurality deployable from the microcatheter tube.

22. The device of claim 17, wherein the electrodes are positionable such that applied electric fields are substantially aligned with division axes of dividing cancerous cells in the ablation volume.

23. A system for energy delivery and induction of mild hyperthermia in a target tissue region for preferential cancerous tissue ablation, comprising:

a probe having a plurality of electrodes positionable at a target tissue region, the plurality of electrodes deployable from a distal portion of the probe so as to at least partially define an ablation volume and provide electric fields extending through the volume;

an energy source coupled to the device to provide electrical current to induce mild hyperthermia comprising an average tissue temperature less than about 48 degrees C., so as to preferentially ablate cancerous cells of the target tissue disposed in the volume.

24. The system of claim 23, wherein the energy source is powered by a battery.

25. The system of claim 23, wherein the system comprises an electrically floating system.

26. The system of claim 23, further comprising a feedback unit for detecting a characteristic of tissue of the target tissue region, a characteristic comprising impedance and/or temperature and/or pH.

27. The system of claim 23, further comprising a tissue removal system.

28. The system of claim 23, further comprising an imaging system.

29. The system of claim 23, further comprising a computer coupled to the energy source to output a signal for a selected treatment current parameter for application to the target tissue.

30. The system of claim 23, the selected treatment parameter comprising current, voltage and frequency.

31. The system of claim 30, the selected treatment parameter comprising duration of an applied current.

32. The system of claim 32, the selected duration selected from a range of about 15 minutes to about 8 hours.

33. The system of claim 32, the selected duration is less than 180 minutes.